62 related articles for article (PubMed ID: 16756799)
1. [Regulation of cytokine production in inflammatory bowel disease].
Ferrero-Miliani L; Seidelin JB; Nielsen OH
Ugeskr Laeger; 2006 May; 168(19):1847-50. PubMed ID: 16756799
[TBL] [Abstract][Full Text] [Related]
2. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.
Feldmeyer L; Keller M; Niklaus G; Hohl D; Werner S; Beer HD
Curr Biol; 2007 Jul; 17(13):1140-5. PubMed ID: 17600714
[TBL] [Abstract][Full Text] [Related]
3. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
4. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
5. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens.
Brodsky IE; Monack D
Semin Immunol; 2009 Aug; 21(4):199-207. PubMed ID: 19539499
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
7. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
Siddique I; Hasan F; Khan I
Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
[TBL] [Abstract][Full Text] [Related]
9. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?
Trendelenburg G
J Cereb Blood Flow Metab; 2008 May; 28(5):867-81. PubMed ID: 18212795
[TBL] [Abstract][Full Text] [Related]
10. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms involved in inflammasome activation.
Bryant C; Fitzgerald KA
Trends Cell Biol; 2009 Sep; 19(9):455-64. PubMed ID: 19716304
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory caspases and inflammasomes: master switches of inflammation.
Martinon F; Tschopp J
Cell Death Differ; 2007 Jan; 14(1):10-22. PubMed ID: 16977329
[TBL] [Abstract][Full Text] [Related]
13. Dextran sulfate sodium enhances interleukin-1 beta release via activation of p38 MAPK and ERK1/2 pathways in murine peritoneal macrophages.
Kwon KH; Ohigashi H; Murakami A
Life Sci; 2007 Jul; 81(5):362-71. PubMed ID: 17628610
[TBL] [Abstract][Full Text] [Related]
14. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
15. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease.
Selvam R; Maheswari P; Kavitha P; Ravichandran M; Sas B; Ramchand CN
Indian J Biochem Biophys; 2009 Feb; 46(1):79-85. PubMed ID: 19374258
[TBL] [Abstract][Full Text] [Related]
16. Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.
Deng X; Tamai R; Endo Y; Kiyoura Y
Toxicol Appl Pharmacol; 2009 Feb; 235(1):97-104. PubMed ID: 19063908
[TBL] [Abstract][Full Text] [Related]
17. The role of TNFalpha in ulcerative colitis.
Sands BE; Kaplan GG
J Clin Pharmacol; 2007 Aug; 47(8):930-41. PubMed ID: 17567930
[TBL] [Abstract][Full Text] [Related]
18. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
[TBL] [Abstract][Full Text] [Related]
19. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.
Faustin B; Lartigue L; Bruey JM; Luciano F; Sergienko E; Bailly-Maitre B; Volkmann N; Hanein D; Rouiller I; Reed JC
Mol Cell; 2007 Mar; 25(5):713-24. PubMed ID: 17349957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
